This was accompanied by changes in the tumor microenvironment: increased matrix deposition (which could contribute to higher p-MLC2) and higher numbers of immunosuppressive populations, in particular CD206+ macrophages and forkhead box P3 (FOXP3+) regulatory T cells (Tregs). The gene discussed is MYL9; the disease is neoplasm.